AUSTRALIA & NEW ZEALAND BREAST CANCER TRIALS GROUP
To eradicate all suffering from breast cancer through the highest quality clinical trials research.
To be a global and regional leader in research collaboration committed to a world without breast cancer.
Excellent, Relevant, Transparent, Reputable, Inclusive, Innovative.
The Australia and New Zealand Breast Cancer Trials Group is the largest independent, oncology clinical trials research group in Australia and New Zealand. It has for more than 35 years conducted clinical trials for the treatment, prevention and cure of breast cancer.
The research program involves multicentre national and international clinical trials and brings together over 700 researchers in 84 institutions throughout Australia and New Zealand. This collaboration ensures that knowledge is shared, resources are pooled and progress is faster.
Clinical trials are the essential tool to identify if a treatment or treatment strategy is safe, effective and has the potential to save lives. All new treatments or treatment strategies are rigorously tested through the clinical trials process before they are made widely available to the community.
The ANZBCTG pursues a policy in its clinical trials program of evaluating treatment efficacy (is there scientific evidence that a treatment works); quality of life (how well do patients tolerate a new treatment); and cost-effectiveness (how affordable is the new treatment for the community). All research conducted by the ANZBCTG is carried out to the highest ethical and regulatory standards.
In 1994, the ANZBCTG Board of Directors established the fundraising and education department, Breast Cancer Institute of Australia, to increase awareness and seek ongoing funding for the ANZBCTG research program.
The ANZBCTG is one of the most successful, respected and longest established breast cancer research groups in the world. The research program plays a pivotal role in influencing breast cancer practice globally contributing to better outcomes for thousands of women in Australia and New Zealand, and potentially millions more throughout the world.